GlassScriptPhysician profile
Christopher J Allen
NPI 1598999872
$38,240.88
in general payments reported to CMS, 2019-2025
22 companies · $29K in 2025
The $29K reported for 2025 was more than what 96% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
See the full distribution for Neurology with Special Qualifications in Child Neurology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $859 · 2020: $2,681 · 2021: $2,771 · 2022: $221 · 2023: $80.65 · 2024: $2,192 · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Consulting Fee: $1,600 · Food and Beverage: $1,388 · Travel and Lodging: $1,272 · Education: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,305.00 |
| Consulting Fee | $1,600.00 |
| Food and Beverage | $1,387.82 |
| Travel and Lodging | $1,272.41 |
| Education | $142.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $19,790.09 | 2024-2025 | Zepbound, Mounjaro |
| Jazz Pharmaceuticals INC. | $12,001.84 | 2019-2025 | |
| Livanova USA, INC. | $1,819.99 | 2020 | |
| Resmed Corp | $1,632.25 | 2019-2024 | |
| Inspire Medical Systems, INC. | $925.15 | 2021-2025 | Inspire |
| Supernus Pharmaceuticals, INC. | $596.62 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $340.98 | 2019-2020 | |
| Harmony Biosciences LLC | $234.89 | 2020-2025 | |
| Ucb, INC. | $149.38 | 2019-2024 | Briviact |
| Axsome Therapeutics, INC. | $115.15 | 2024-2025 | Sunosi |
| Noctrix Health, INC. | $99.42 | 2024 | Nidra |
| Arbor Pharmaceuticals, INC. | $85.43 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $76.92 | 2024 | Koselugo |
| Eisai INC. | $76.47 | 2019 | |
| Neurelis, INC. | $69.03 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avadel Cns Pharmaceuticals, LLC | $60.95 | 2024-2025 | Lumryz |
| Zoll Respicardia, INC. | $45.72 | 2024-2025 | Remede System |
| Vanda Pharmaceuticals INC. | $28.78 | 2020 | |
| Pyros Pharmaceuticals, INC. | $28.63 | 2024 | Vigpoder |
| Upsher-Smith Laboratories LLC | $26.92 | 2025 | |
| Acadia Pharmaceuticals INC | $20.04 | 2025 | Daybue |
| Idorsia Pharmaceuticals US INC | $16.23 | 2024 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.